摘要
2019年12月以来,湖北省武汉市陆续出现2019新型冠状病毒(2019-nCoV,SARS-CoV-2)感染病例,疫情持续蔓延,全国其他地区也相继发现了此类病例。新型冠状病毒肺炎疫情给胸外科临床实践带来了巨大挑战。门诊需要加强对磨玻璃影及肺内斑块影病例的鉴别诊断。疫情期间严格控制手术指征,推迟择期手术;拟行限期手术患者,需隔离2周且核酸检测阴性后,方可开展手术;在疫区拟行急诊手术患者,术前应注意排查是否合并新型冠状病毒感染,必要时行核酸检测;拟行急诊手术患者,必要时术前应开展核酸检测,术中按三级防护处理。严格开展手术消毒隔离措施。在术后患者中,积极排查合并新型冠状病毒感染患者。在新型冠状病毒感染患者抢救过程中,需要注意预防、治疗相关并发症,包括机械通气相关性气胸或纵隔气肿以及气管插管后损伤。
Since December 2019,a novel coronavirus(2019-nCoV,SARS-CoV-2)pneumonia(COVID-19)outbreak has occurred in Wuhan,Hubei Province,and the epidemic situation has continued to spread.Such cases have also been found in other parts of the country.The spread of the novel coronavirus pneumonia epidemic has brought great challenges to the clinical practice of thoracic surgery.Outpatient clinics need to strengthen the differential diagnosis of ground glass opacity and pulmonary plaque shadows.During the epidemic,surgical indications are strictly controlled,and selective surgery is postponed.Patients planning to undergo a limited period of surgery should be quarantined for 2 weeks and have a nucleic acid test when necessary before surgery.For patients who are planning to undergo emergency surgery,nucleic acid testing should be carried out before surgery,and three-level protection should be performed during surgery.Patients who are planning to undergo emergency surgery in the epidemic area should be confirmed with or without novel coronavirus pneumonia before operation,and perform nucleic acid test if necessary.Surgical disinfection and isolation measures should be strictly carried out.Among postoperative patients,cases with new coronavirus infection were actively investigated.For the rescue of patients with novel coronavirus infection,attention needs to be paid to prevention and treatment and related complications,including mechanical ventilation-related pneumothorax or mediastinal emphysema,and injury after tracheal intubation.
作者
谢冬
王思桦
姜格宁
廖永德
朱余明
张雷
徐志飞
陈克能
方文涛
葛棣
谭黎杰
陈晓峰
李鹤成
吴创炎
童松
刘峥
丁祥超
陈玖玲
程超
王海峰
陈昶
XIE Dong;WANG Sihua;JIANG Gening;LIAO Yongde;ZHU Yuming;ZHANG Lei;XU Zhifei;CHEN Keneng;FANG Wentao;GE Di;TAN Lijie;CHEN Xiaofeng;LI Hecheng;WU Chuangyan;TONG Song;LIU Zheng;DING Xiangchao;CHEN Jiuling;CHENG Chao;WANG Haifeng;CHEN Chang(Department of Thoracic Surgery,Shanghai Pulmonary Hospital,Tongji University,Shanghai,200433,P.R.China;Department of Thoracic Surgery,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,430022,P.R.China;Department of Minimally Invasive Thoracic Surgery Center,Shanghai Changzheng Hospital,Second Military Medical University,Shanghai,200003,P.R.China;The First Department of Thoracic Surgery,Cancer Hospital and Institute,Peking University,Beijing,100142,P.R.China;Department of Thoracic Surgery,Shanghai Chest Hospital,Medical School of Shanghai Jiaotong University,Shanghai,200030,P.R.China;Department of Thoracic Surgery,Zhongshan Hospital,Shanghai Medical College,Fudan University,Shanghai,200032,P.R.China;Department of Thoracic Surgery,Huashan Hospital,Shanghai Medical College,Fudan University,Shanghai,200040,P.R.China;Department of Thoracic Surgery,Ruijin Hospital,Medical School of Shanghai Jiaotong University,Shanghai,200025,P.R.China;Department of Thoracic Surgery,West China Hospital,Sichuan University,Chengdu,610041,P.R.China;Department of Thoracic Surgery,Renmin Hospital,Wuhan University,Wuhan,430060,P.R.China)
出处
《中国胸心血管外科临床杂志》
CAS
CSCD
2020年第4期359-363,共5页
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
基金
上海肺科医院临床研究基金(fk1936,fk1943)
上海市卫生健康委员会(2018ZHYL0102,2019SY072)。
